Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “g-csf”

6 pharma patents match "g-csf" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "g-csf" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “g-csf” · 30,257 patents in full index Clear search

  1. US 12421308

    Anti-G-CSF antibodies and uses thereof

    ME Therapeutics Inc. · Granted Sep 23, 2025 · Expires Sep 18, 2045

    granted
  2. US 12246059

    Stable hybrid FC fusion G-CSF formulation

    ILKOGEN ILAÇ SANAYI VE TICARET A.S. · Granted Mar 11, 2025 · Expires Mar 6, 2045

    granted
  3. US 11813310

    Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia

    ILKOGEN ILAÇ SANAYI VE TICARET A.S. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  4. US 10813913

    Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)

    United States Government as represented by the Department of Veterans Affairs · Granted Oct 27, 2020 · Expires Oct 22, 2040

    granted
  5. US 10376495

    Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)

    The United States Government as Represented by the Department of Veterans · Granted Aug 13, 2019 · Expires Aug 8, 2039

    granted
  6. US 8524655

    Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders

    Northwestern University · Granted Sep 3, 2013 · Expires Aug 29, 2033

    granted